Clinical trial
The Effect of Restrictive Fluid and Vasopressin During Surgery of Burn Patients: a Randomized Clinical Trial
NCT03590873 is registered in ClinicalTrials.gov with Hangang Sacred Heart Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Restrictive Fluid and Vasopressin During Surgery of Burn Patients: a Randomized Clinical Trial
- Lead sponsor
- Hangang Sacred Heart Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- July 25, 2018
- Completion date
- June 4, 2019
- Enrollment
- 158 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
burn surgery